BriaCell Therapeutics BCTX
NASDAQ BCTX
$4.08 -0.08 (-1.81%)
At close: Sep 29, 2026 · 4:00 PM EDT

BriaCell Therapeutics (BCTX) Interest Coverage Ratio (2021 - 2026)

Updated

BriaCell Therapeutics' (BCTX) Interest Coverage Ratio came in at -257.19 for fiscal Q3 2026 (quarter ended Apr 30, 2026), compared with -171.13 a year earlier.

Analysis

BriaCell Therapeutics (BCTX) Interest Coverage Ratio (2021 - 2026) Analysis & Trends

For the trailing twelve months through Apr 30, 2026, Interest Coverage Ratio at BriaCell Therapeutics was -480.85; for FY2025 (ended Jul 31, 2025), it was -735.68.

  • In prior fiscal years, BriaCell Therapeutics' Interest Coverage Ratio was -15616.90 in FY2022 and -151.34 in FY2021.
  • The fiscal Q3 2026 figure stands as the lowest quarterly Interest Coverage Ratio since fiscal Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.41
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 10.28
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 7.27
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 5.22
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -42.08
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 BriaCell Therapeutics 30.16 Mn 29.51 Mn - -257.19
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -257.19
Apr 30, 2025 -171.13
Oct 31, 2021 -2,333.82
Jul 31, 2021 -20.54
Apr 30, 2021 -77.01
Jan 31, 2021 -4.15
API Access

BriaCell Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=BCTX&period=max&api_key=YOUR_API_KEY